BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32473242)

  • 1. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
    Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.
    Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL
    Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression.
    Cao N; Yu Y; Zhu H; Chen M; Chen P; Zhuo M; Mao Y; Li L; Zhao Q; Wu M; Ye M
    Cell Death Dis; 2020 May; 11(5):351. PubMed ID: 32393761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer
    Tian J; Wang W; Zhu J; Zhuang Y; Qi C; Cai Z; Yan W; Lu W; Shang A
    J Immunol Res; 2022; 2022():4012920. PubMed ID: 35497876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53.
    Chen K; Zhang F; Ding J; Liang Y; Zhan Z; Zhan Y; Chen LH; Ding Y
    J Cancer; 2017; 8(16):3318-3330. PubMed ID: 29158805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.
    Shang W; Wang Y; Liang X; Li T; Shao W; Liu F; Cui X; Wang Y; Lv L; Chai L; Qu L; Zheng L; Jia J
    J Pathol; 2021 Feb; 253(2):148-159. PubMed ID: 33044755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab promotes SN38 sensitivity via suppression of heat shock protein 27 in colorectal cancer cells with wild-type RAS.
    Ishida T; Ishii Y; Tsuruta M; Okabayashi K; Akimoto S; Koishikawa K; Hasegawa H; Kitagawa Y
    Oncol Rep; 2017 Aug; 38(2):926-932. PubMed ID: 28656305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR.
    Xing Y; Jing H; Zhang Y; Suo J; Qian M
    Int J Biochem Cell Biol; 2020 Jan; 118():105643. PubMed ID: 31704502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer.
    Zhao LH; Li Q; Huang ZJ; Sun MX; Lu JJ; Zhang XH; Li G; Wu F
    Cell Death Dis; 2021 Oct; 12(11):974. PubMed ID: 34671018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
    Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
    PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
    Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
    Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Silencing of CHOP Expression by the Histone Methyltransferase EHMT1 Regulates Apoptosis in Colorectal Cancer Cells.
    Kim K; Ryu TY; Lee J; Son MY; Kim DS; Kim SK; Cho HS
    Mol Cells; 2022 Sep; 45(9):622-630. PubMed ID: 35748228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.
    Gao H; Yu Z; Bi D; Jiang L; Cui Y; Sun J; Ma R
    Mol Cell Biochem; 2007 Nov; 305(1-2):35-44. PubMed ID: 17577629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
    Lee J; Lee I; Han B; Park JO; Jang J; Park C; Kang WK
    J Natl Cancer Inst; 2011 Apr; 103(8):674-88. PubMed ID: 21398618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
    Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
    Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
    Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.